Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacLennan, D. H.
Right arrow Articles by Green, N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacLennan, D. H.
Right arrow Articles by Green, N. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 46, Issue of November 14, 1997 pp. 28815-28818

MINIREVIEW:
The Mechanism of Ca2+ Transport by Sarco(Endo)plasmic Reticulum Ca2+-ATPases*

David H. MacLennan Dagger §, William J. Rice Dagger and N. Michael Green par

From the Dagger  Banting and Best Department of Medical Research, C. H. Best Institute, University of Toronto, Toronto, Ontario M5G 1L6, Canada and the par  National Institute for Medical Research, The Ridgeway, Mill Hill, London NW71AA, United Kingdom

Function
Structure
Structure/Function Relationships
Mechanism of Ca2+ Transport
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


Function

Ca2+ pumps, together with Ca2+ release channels, form ubiquitous Ca2+ regulatory systems in muscle and non-muscle cells. The sarco(endo)plasmic reticulum Ca2+-ATPases (SERCA)1 and the plasma membrane Ca2+-ATPases have the highest affinity for Ca2+ removal from the cytoplasm and, together, set resting cytoplasmic Ca2+ concentrations. Three differentially expressed genes encode SERCA proteins (1). SERCA1a and -1b are expressed in fast-twitch skeletal muscle, but loss of SERCA1 function in Brody disease is sufficiently compensated to preserve life (2). SERCA2a is the cardiac/slow-twitch isoform, whereas SERCA2b, with a C-terminal extension, is expressed in smooth muscle and non-muscle tissues. It is almost certainly an essential gene. SERCA3 is expressed in a limited set of non-muscle tissues, including endothelial, epithelial, and lymphocytic cells and platelets, and its knockout is not lethal (3).

SERCA enzymes are typical of the class of P-type ATPases, which form a phosphoprotein intermediate and undergo conformational changes during the course of ATP hydrolysis (4, 5). Some of the conformational states can be stabilized, either by adjustment of reaction conditions or through mutagenesis, and characterized as intermediates in the overall reaction cycle (Fig. 1A). The phosphorylated intermediate, E1P(Ca)2, can phosphorylate ADP, whereas E2P can only react with water. The formation of E1P requires that two high affinity Ca2+ binding sites be occupied. The enzyme is then phosphorylated by ATP and, concomitantly, the two Ca2+ ions are occluded and can no longer exchange with cytoplasmic Ca2+. The rate-limiting transition to E2P is accompanied by loss of Ca2+ into the lumen, the affinity having fallen by 3 orders of magnitude. Hydrolysis of E2P and regeneration of the high affinity Ca2+ binding sites (E1(Ca)2) complete the reversible cycle. High lumenal Ca2+ drives the formation of E1P from phosphate (Pi), and its effect on the level of E1P led Jencks (5, 6) to postulate a second set of Ca2+ binding sites on the lumenal surface. Proton countertransport, involving the exchange of one H+ per Ca2+, has been shown during the reaction cycle (7), emphasizing the similarity between Ca/H- and Na/K- or H/K-ATPases.


Fig. 1. A, reaction cycle for Ca2+ transport by SERCA pumps, illustrating points where mutations either block Ca2+ transport at different stages (1, Ca2+ binding or affinity; 2, ATP binding; 3, phosphorylation; 4, E1P right-arrow E2P; 5, E2P dephosphorylation) or release occluded Ca2+ to the cytoplasmic surface (6, uncoupling). Parentheses around Ca2+ or H+ indicate occlusion. B, a model of SERCA1a structure in the absence of ATP and Ca2+. The surfaces of the bilayer are indicated by the two shadow planes. (Reprinted with permission from Nature (13), copyright 1993, MacMillan Magazines Ltd.)

[View Larger Version of this Image (38K GIF file)]



Structure

Two-dimensional arrays and helical tubes of SERCA1a were first produced by treatment of native membranes with decavanadate, and in a negative stain, these yielded a three-dimensional structure with a resolution of 25 Å (8). At high Ca2+ concentration, thin plates were obtained, which have given a 6-Å projection map (8, 9). Thapsigargin, a SERCA-specific inhibitor (10) that appears to bind to the M3 transmembrane sequence (11), stabilizes the E2 state of the pump and promotes formation of helical tubes (12). These are also compatible with bound nucleotides, but they are disrupted by low Ca2+. In contrast, the thin plates, probably corresponding to E1(Ca)2, are disrupted by thapsigargin and by nucleotides.

Current modeling is based on a 14-Å structure (Fig. 1B) obtained by cryoelectron microscopy of decavanadate tubes (13). A large cytoplasmic head is linked to the membrane by a narrow stalk. The protein within the membrane is divided into two major densities, A1 and A2, lying beneath the stalk, and two minor densities, B and C, to one side. A recent structure for the CrATP-bound complex (14) locates the nucleotide binding site in the groove on the underside of the head (Fig. 1B).


Fig. 2. A planar illustration of the structure of SERCA1a in which the amino acid sequence is laid out in accordance with assigned domains and probable secondary structure (15) (stacked sequences of three or four residues represent alpha -helices, zigzag alternations represent beta -strands, and linear sections represent loops). Mutated residues are color coded as follows: red, loss of function; yellow, partial loss of function; green, retention of function. Many of the mutations in the sequence between residues 365 and 412 were carried out with SERCA2a.

[View Larger Version of this Image (77K GIF file)]


Two main segments of sequence (Fig. 2) form the cytoplasmic head and stalk (Fig. 1B) (15). The segment of about 130 residues following the M1/M2 hairpin, likely to form a 7-8-membered beta -strand domain, is linked by long, amphipathic helices, S2 and S3, to M2 and M3. A central segment of about 440 residues forms the main head region. It includes the phosphorylation site at Asp351 and widely separated residues such as Lys492, Lys515, Cys674, Lys684, Asp703, and Asp707, which are affinity labeled by various nucleotide analogues in either Ca2+ or homologous Na/K-ATPases (16). The N and C termini of the central domain form stalk helices S4 and S5, which link M4 to the phosphorylation site and M5 to the hinge region.

The bulk of the central domain is predicted to be a mixture of alpha -helices and beta -strands, which alternate fairly regularly in the C-terminal half, a characteristic associated with nucleotide binding, but less regularly in the N-terminal half, referred to as the phosphorylation domain. The phosphorylation domain extends to the variable sequence preceding Lys492, which is labeled by 8-azido-TNP-ATP (17), and is likely to be part of the nucleotide binding domain. On the basis of a 20-residue Walker B region and an overall beta -alpha -beta pattern of secondary structure, kinase-related folds in the nucleotide binding region were proposed (18). However, the inclusion of Lys492 implicated an extra antiparallel beta -strand in this domain, which together with immunological evidence for an exposed epitope on the central strand of the beta -sheet (19, 20) suggests that this region has a new fold specific to P-type pumps.

The C terminus of the nucleotide binding domain, close to the top of the stalk, is highly conserved and may form a subdomain, which by analogy with some kinases could form a hinge between phosphorylation and nucleotide binding domains. Several sites in this hinge region are labeled by gamma -phosphate-linked affinity labels, suggesting that it is close to the phosphorylation site (16).

The sequences of all P-type ion pumps, except for the shorter ones mostly specific for copper or cadmium, show a common pattern of hydrophobicity (21). A 10-transmembrane helix model for SERCA1a and SERCA2a (Fig. 3) was proposed on the basis of analysis of hydrophobicity (15). It has received growing support (16, 20) from well controlled experiments with proteases, antibodies, and sulfhydryl labels, which showed the N and C termini to be cytoplasmic and the M7/M8 loop to be lumenal, and from proteolysis of intact vesicles with trypsin, which led to the isolation of hydrophobic fragments corresponding to M1/M2, M3/M4, M5/M6, and M7/M8 (22). Evidence for the M9/M10 hairpin comes from experiments involving in vitro insertion of this hairpin into membranes using eukaryotic expression vectors encoding a series of membrane inserts (23). The volume of the transmembrane domain, as deduced from a 14-Å structure (21), will accommodate 10-transmembrane helices.


Fig. 3. Alternative models of the location of the two Ca2+ binding sites within transmembrane helices M4, M5, and M6. A, assignment of ligands to "stacked" Ca2+ binding sites (27, 29, 30). B, different views (schematic, cross-section, and oblique) of a "side-by-side" placing of Ca2+ binding sites, consistent with cross-linking results and with a helical structure for M6 (35). E4, Glu309 in M4; E5, Glu771 in M5; N6, Asn796 in M6; T6, Thr799 in M6; D6, Asp800 in M6; E8, Glu908 in M8. Ca2+ binding ligands are indicated in red, whereas Ca2+ is indicated in yellow. In the schematic view of the side-by-side model, the possibility of additional or alternative entry and exit sites is indicated by gray arrows. The oblique view consists of a series of tilted discs representing the seven tiers of the helical nets illustrated in Fig. 2. This view clarifies the proposed geometry of the sites but does not show the proposed right-handed coiling of the helices. Thr799 in M6 is partially obscured.

[View Larger Version of this Image (39K GIF file)]


Tentative assignments of the 10-transmembrane helices (Fig. 3) to the four transmembrane regions, A1, A2, B, and C (Fig. 1B), have been made (13, 21) but will be subject to refinement. M2, M3, M4, and M5, which underlie the stalk, must occupy part of A1, but differing slopes of helices below the stalk would permit crossover to other regions. Since M4, M5, and M6 must cluster to form the Ca2+ binding sites (see below), M6 must lie close, making it a strong candidate for A2. This places the entrance to the Ca2+ binding sites to one side of the stalk on the boundary between A1 and A2. The small lumenal domain joins the A2 region to the B region. Since the only long loop (38 residues) on that side of the membrane joins M7 to M8, the M7/M8 hairpin can be associated with both A2 and B. Cytoplasmic densities near the membrane surface, above the A1 and C regions, could represent N and C termini, respectively. If so, M9 and M10 might occupy the C region, whereas M1 might be located in A1. A second approach to helix arrangement involves analysis of conserved (internal) and variable (lipid-exposed) sites in the transmembrane sequences of diverse Ca2+ pumps (21).


Structure/Function Relationships

Mutagenesis

Site-directed mutagenesis has provided key insights into structure/function relationships in SERCA1 and SERCA2 (24, 25). In these experiments, mutated cDNA is expressed transiently in heterologous cell culture, microsomal vesicles are isolated, and overall and partial reactions of ATP-dependent Ca2+ transport are assayed. In Fig. 3, loss of function, reduced function, and unaltered function mutants in SERCA1 or SERCA2 are located relative to predicted structural domains.

Ca2+ Binding Mutants

Two principles were key to the characterization of two Ca2+ binding sites through mutagenesis. These were: (i) that binding of Ca2+ to the first site (site I), presumably the more distal from the cytoplasm, leads to cooperative binding to the second, presumably more proximal site (site II) (6, 26); and (ii) occupation of both Ca2+ binding sites I and II is required for "forward" phosphorylation from ATP, whereas occupation of site I alone is sufficient to convert Pi-reactive E2 conformations to non-reactive E1, thereby depleting the substrate for "reverse" phosphorylation from Pi (25, 27) (Fig. 1).

The initial mutagenic screen identified Glu309 in M4, Glu771 in M5, Asn796, Thr799, and Asn800 in M6, and Glu908 in M8 as potential Ca2+ binding ligands (28). Mutants were Ca2+ transport negative and not phosphorylated by ATP plus Ca2+; for all but N796A, high Ca2+ did not prevent reverse phosphorylation, suggesting that mutation of any of these residues would lead to the loss of at least one Ca2+ binding site. The first measurements of reverse phosphorylation were carried out at pH 6.4, but later measurements, carried out at neutral pH, showed normal Ca2+ inhibition of phosphorylation from Pi for mutants E309Q as well as for N796A (29, 30). These results are consistent with retention of Ca2+ binding site I, implying that both Glu309 and Asn796 contribute to site II. This conclusion was supported by the direct demonstration that mutant E309Q retains a single Ca2+ binding site and that, at pH 6.4, Ca2+ can gain access to the site (presumably from the lumenal side) in detergent-disrupted membranes but not in intact vesicles (31).

By contrast, mutants E771Q, T799A, and E908A showed similar, very low Ca2+ affinity in both forward and reverse phosphorylation assays, implying that site I was disrupted (29, 30). Mutant D800N showed reduced Ca2+ affinity in both assays but to different extents, suggesting that Asp800 was contributing to both sites. In the plasma membrane Ca2+-ATPases, which transport only a single Ca2+, the residues homologous to Glu771, Thr799, and Glu908, all assigned to site I, are replaced by Ala, Met, and Gln, respectively (32).

Mutants E309N, E771Q, N796A, T799A, D800N, as well as G310P and G801V (but not G770A) lost the ability to occlude Ca2+ in the presence of CrATP (25, 30, 33). By contrast, E908Q retained full function (mutants E309Q, E771Q, and D800N are non-functional), and the mutant E908A retained Ca2+ occlusion and transport with low affinity (25). These observations, together with the fact that Glu908 is the only mutation-sensitive residue in all of M8 (34), suggest, at best, a peripheral role in Ca2+ binding and transport for Glu908 and for helix M8.

The location of Ca2+ ligands on separate helices means that correct helix orientation will be crucial for the formation of high affinity Ca2+ binding sites and that reorientation coupled to movements of the cytoplasmic domains could cause occlusion and changes in Ca2+ affinity. The packing of these helices is being studied by introduction of pairs of cysteines into selected positions and assay of the expressed products for cross-linking (35). Cross-links observed at different tiers of helices M4 and M6 (A305C/L793C, E309C/N796C, T317C/A804C) are in relative positions i, i + 4, i + 12, favoring packing of M4 and M6 as a right-handed supercoil at an angle of about 40°. It would normally be difficult to maintain such a large angle over several turns of helix, but the presence of four prolines and three glycines could permit sufficient curvature.

Insights from cross-linking data provide a possible solution to a problem raised by the assignment of Ca2+ ligands to two sites in a model with the two sites stacked one above the other (Fig. 3A) (25, 26). Stacking leads to the placement of Asn796 in the more cytoplasmic site (site II), even though it is the most lumenal ligand. Andersen (25) suggested that this might be resolved if M6 were not fully helical. However, if M4 and M6 are oriented to optimize cross-links between them, as indicated in Fig. 3B (cross-section), then Glu309, Asn796, and Asp800 would be positioned near the M4/M6 contact, whereas Thr799 would lie to the right of this contact. If M5 is placed so that Glu771 is apposed to Thr799 in M6, then the ligands between M4 and M6 are those assigned to site II (Glu309, Asn796), whereas the ligands between M5 and M6 are those assigned to site I (Glu771, Thr799). Asp800 in M6 would be in a position to contribute to both sites. This new "side-by-side sites" model has the advantage that Asn796, which lies below Asp800 in the helix (Fig. 3B, oblique view), can contribute to site II without distortion of the M5/M6 helices. Positioning of M8 so that Glu908 would be apposed to site I would permit its peripheral contribution to that site.

The side-by-side sites model would mean that the pathway of Ca2+ translocation would follow an angular course (Fig. 3B, schematic, large arrows) rather than a direct pathway (Fig. 3A, schematic). In both schemes, occupation of site I by Ca2+ initiates cooperative binding to site II, locking in Ca2+ at site I, but in the side-by-side sites model Ca2+ entry to site II could be through an independent pathway (small arrows). Randomization could follow when links are weakened following occlusion, and exit could be independent or through a single pathway (small or large arrows). There is, however, evidence for interaction during exit, since occupation of the more lumenal site (presumably site I) prevents dissociation from the more cytoplasmic site, the inverse of the behavior at the cytoplasmic surface (6).

Scanning mutagenesis revealed that relatively small residues lying within discrete patches on the helix surfaces in the three turns surrounding the five Ca2+ ligands in M4, M5, and M6 (Fig. 2), when mutated, block pump activity at a variety of different steps in the reaction cycle (34). By contrast, only a few of the residues in the top and bottom two turns of M4, M5, and M6 are sensitive to mutation and, overall, are much larger, especially in M5. This concentration of small residues in the middle of the membrane could provide a polar cavity with the larger surface residues controlling access to it. In M5 the replacement of the bulky Tyr763, above Glu771 and near the top of M5, by the tiny Gly gives an uncoupled mutant (36) in which Ca2+ escapes to the cytoplasm before it can be translocated (Fig. 1). At the bottom of M4, the mutation-sensitive Lys297 (28, 37) has a suitable charge, size, and position to function as a gating residue for release of Ca2+ to the lumen.

A double mutant, D813A/D818A, in the M6/M7 loop causes loss of Ca2+-ATPase activity and loss of the ability of Ca2+ to prevent phosphorylation from Pi (38). This loop could form part of the entry portal to Ca2+ binding sites I and II or be part of the gate operating during occlusion.

A motif in the mutation-sensitive regions of M4 and M6, (E/D)GLPA(V/T), suggests a sequence duplication (34). A sequence in the same region of M5 (SSNVGE) is related when reversed. However, since there is no symmetry in the ligands contributed by M4, M5, and M6 to the Ca2+ binding and transport site, the significance of the similarity in this triad of binding sequences is not clear.

ATP Binding Mutants

Mutagenesis of highly conserved sequences in the large cytoplasmic domain between M4 and M5 showed that many mutants did not form phosphoenzyme intermediates from either ATP or Pi, consistent with, but not proving, their involvement in ATP binding (39, 40). Measurement of ATP binding affinity through competitive inhibition of [gamma -32P]8-azido-TNP-ATP photolabeling is a promising recent assay (41). With this assay, mutants of Phe487, Arg489, and Lys492 were found to have altered ATP dependence of ATPase activity in low, intermediate, and high ATP concentration ranges, showing their involvement in both catalytic and regulatory ATP binding. Mutants in Phe487 also failed to show CrATP-dependent Ca2+ occlusion.

Conformation Change Mutants

The crucial labile intermediate E1P(Ca)2 normally loses its ADP sensitivity and its Ca2+ within a few hundred milliseconds, but the intermediate can be stabilized. A number of site-directed mutations in all the major domains block this step (24, 25), showing that the conformational effects accompanying E1P right-arrow E2P involve all of these domains. Mutants that affect hydrolysis of E2P have so far been found only in M4, M5, and M6, implying that a limited, long range interaction between cytoplasmic and transmembrane sites controls this step.

Chemical and Physical Probes of Conformational Changes

The wide separation of phosphorylation sites and Ca2+ sites within the ATPase molecule implies long distance transmission of conformational effects, whereas the rigid domains and long helices provide a plausible medium for their transmission. Although the nature and extent of conformational changes cannot be defined without a detailed structure, a variety of chemical and physical methods have been employed to detect conformational changes and, in some cases, to follow their kinetics. Cross-linking of the hinge domain to the N terminus of the nucleotide binding domain blocks E1P right-arrow E2P (42), providing evidence for essential domain movements. Analysis of x-ray diffraction following the photolysis of caged ATP (43) or comparisons of structural features of the enzyme crystallized in two different conformations (44) provide evidence for large global changes consistent with domain movements. Large domain movements, however, are not reflected in changes in CD (45), in intrinsic fluorescence, or in excitation energy transfer between bound dyes (46). FTIR difference spectra in which absorption bands can be assigned to specific bond types (8, 47, 48) show that 10-15 residues may be involved and that the observed kinetic constants are independent of the absorption band used. FTIR results provide direct evidence for small conformational changes accompanying Ca2+ binding, ATP binding, E1P right-arrow E2P, and hydrolysis of E2P.


Mechanism of Ca2+ Transport

A basic mechanism for a P-type pump, illustrated in Fig. 4, takes into account the characteristics of the transport process and the structure of the pump (24). The Ca2+ binding and translocation sites are in a cavity between M4, M5, and M6, where they are formed by the precise juxtaposition of Ca2+ binding residues located in these three helices. Access to the cavity is controlled by interactions between the larger residues near the cytoplasmic ends of the helices. The phosphorylation-induced domain movements that close off cytoplasmic access to the cavity will initiate occlusion. If such movements involved M4, M5, or M6, they might also be expected to disrupt the precise placement of the ligands required to form high affinity sites, so that, after occlusion, the two Ca2+ ions would be less firmly bound and capable of exchanging their positions, consistent with kinetic observations (49). Further long range, phosphorylation-induced domain movements will open the exit gate, permitting release of weakly bound Ca2+ to the lumen. Later conformational changes will result in dephosphorylation of E2P and reformation of E1(Ca)2, completing the Ca2+ transport cycle.


Fig. 4. Model illustrating the mechanism of Ca2+ transport by SERCA1. A, the structural model (Fig. 1B) is skeletonized to reveal some of the interacting domains. M4, S4, and the phosphorylation domain are blue; the nucleotide binding/hinge domain, S5, and M5 are pink; M6 is yellow; ATP is green; Ca2+ is red. B, the transmembrane domain is simplified by removal of all helices but M4 and M5 so that the essential contribution of M6 to the Ca2+ binding sites must be imagined. In the E1 conformation, high affinity Ca2+ binding sites located near the center of helices M4, M5, and M6 are accessible to cytoplasmic Ca2+ but not to lumenal Ca2+. C, phosphorylation from ATP, following the occupation of both sites by Ca2+, leads to linked movements of both cytoplasmic and transmembrane domains, resulting in occlusion through closure of the entry gate. Ca2+ is now contained in a polar cavity formed near the center of the transmembrane domain by relatively small amino acids and blocked from exit by the juxtaposition of relatively large residues at both ends of the transmembrane helices. D, further conformational changes open the gate allowing exit of the two Ca2+ ions to the lumen. In this conformation Ca2+ affinity is very low. This conformation also activates dephosphorylation and returns the pump to the high Ca2+ affinity form, completing the cycle. (Copyright 1997, Alice Y. Chen.)

[View Larger Version of this Image (77K GIF file)]



FOOTNOTES

*   This minireview will be reprinted in the 1997 Minireview Compendium, which will be available in December, 1997. Original research from the laboratory of D. H. M. was supported by grants from the Medical Research Council of Canada, National Institutes of Health, Heart and Stroke Foundation of Canada, Muscular Dystrophy Association of Canada, and Canadian Genetic Diseases Network of Centers of Excellence.
§   To whom correspondence and reprint requests should be addressed: Banting and Best Dept. of Medical Research, C. H. Best Inst., University of Toronto, 112 College St., Toronto, Ontario M5G 1L6, Canada. Tel.: 416-978-5008; Fax: 416-978-8528; E-mail: david.maclennan{at}utoronto.ca.
   Supported by a studentship from the Medical Research Council of Canada.
1   The abbreviations used are: SERCA, sarco(endo)plasmic reticulum Ca2+-ATPases; 8-azido-TNP-ATP, 8-azido-2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate; FTIR, Fourier-transform infrared spectroscopy.

ACKNOWLEDGEMENTS

We thank Dr. David L. Stokes for discussion, critical reading of the manuscript, and sharing of recent structural information and Alice Y. Chen for illustrations in Fig. 4.


REFERENCES

  1. Wu, K. D., Lee, W. S., Wey, J., Bungard, D., and Lytton, J. (1995) Am. J. Physiol. 269, C775-C784 [Abstract/Free Full Text]
  2. Odermatt, A., Taschner, P. E. M., Khanna, V. K., Busch, H. F. M., Karpati, G., Jablecki, C. K., Breuning, M. H., and MacLennan, D. H. (1996) Nat. Genet. 14, 191-194 [CrossRef][Medline] [Order article via Infotrieve]
  3. Liu, L. H., Paul, R. J., Sutliff, R. L., Miller, M. L., Lorenz, J. N., Pun, R. Y. K., Duffy, J. J., Doetschman, T., Kimura, Y., Machennan, D. H., Hoying, J. B., and Shull, G. E. (1997) J. Biol. Chem. 272, in press
  4. de Meis, L., and Vianna, A. L. (1979) Annu. Rev. Biochem. 48, 275-292 [CrossRef][Medline] [Order article via Infotrieve]
  5. Jencks, W. P. (1992) Ann. N. Y. Acad. Sci. 671, 49-56 [Medline] [Order article via Infotrieve]
  6. Mintz, E., and Guillain, F. (1997) Biochim. Biophys. Acta 1318, 52-70 [Medline] [Order article via Infotrieve]
  7. Yu, X., Carroll, S., Rigaud, J. L., and Inesi, G. (1993) Biophys. J. 64, 1232-1242 [Medline] [Order article via Infotrieve]
  8. Martonosi, A. N. (1995) Biosci. Rep. 15, 263-281 [CrossRef][Medline] [Order article via Infotrieve]
  9. Stokes, D. L., and Green, N. M. (1990) J. Mol. Biol. 213, 529-538 [CrossRef][Medline] [Order article via Infotrieve]
  10. Lytton, J., Westlin, M., and Hanley, M. R. (1991) J. Biol. Chem. 266, 17067-17071 [Abstract/Free Full Text]
  11. Norregaard, A., Vilsen, B., and Andersen, J. P. (1994) J. Biol. Chem. 269, 26598-26601 [Abstract/Free Full Text]
  12. Stokes, D. L., and Lacapere, J. J. (1994) J. Biol. Chem. 269, 11606-11613 [Abstract/Free Full Text]
  13. Toyoshima, C., Sasabe, H., and Stokes, D. L. (1993) Nature 362, 467-471 [Medline] [Order article via Infotrieve]
  14. Yonekura, K., Stokes, D. L., Sasabe, H., and Toyoshima, C. (1997) Biophys. J. 72, 997-1005 [Medline] [Order article via Infotrieve]
  15. MacLennan, D. H., Brandl, C. J., Korczak, B., and Green, N. M. (1985) Nature 316, 696-700 [CrossRef][Medline] [Order article via Infotrieve]
  16. Moller, J. V., Juul, B., and le Maire, M. (1996) Biochim. Biophys. Acta 1286, 1-51 [Medline] [Order article via Infotrieve]
  17. McIntosh, D. B., Woolley, D. G., and Berman, M. C. (1992) J. Biol. Chem. 267, 5301-5309 [Abstract/Free Full Text]
  18. Taylor, W. R., and Green, N. M. (1989) Eur. J. Biochem. 179, 241-248 [Medline] [Order article via Infotrieve]
  19. Mata, A. M., Matthews, I., Tunwell, R. E., Sharma, R. P., Lee, A. G., and East, J. M. (1992) Biochem. J. 286, 567-580
  20. Lee, A. G. (1996) in Biomembranes (Lee, A. G., ed), Vol. 5, JAI Press, Amsterdam
  21. Stokes, D. L., Taylor, W. R., and Green, N. M. (1994) FEBS Lett. 346, 32-38 [CrossRef][Medline] [Order article via Infotrieve]
  22. Shin, J. M., Kajimura, M., Arguello, J. M., Kaplan, J. H., and Sachs, G. (1994) J. Biol. Chem. 269, 22533-22537 [Abstract/Free Full Text]
  23. Bayle, D., Weeks, D., and Sachs, G. (1995) J. Biol. Chem. 270, 25678-25684 [Abstract/Free Full Text]
  24. MacLennan, D. H., Clarke, D. M., Loo, T. W., and Skerjanc, I. S. (1992) Acta Physiol. Scand. 607, 141-150 [Medline] [Order article via Infotrieve]
  25. Andersen, J. P. (1995) Biosci. Rep. 15, 243-261 [CrossRef][Medline] [Order article via Infotrieve]
  26. Inesi, G., Sumbilla, C., and Kirtley, M. E. (1990) Physiol. Rev. 70, 749-760 [Free Full Text]
  27. Andersen, J. P., and Vilsen, B. (1995) FEBS Lett. 359, 101-106 [CrossRef][Medline] [Order article via Infotrieve]
  28. Clarke, D. M., Loo, T. W., Inesi, G., and MacLennan, D. H. (1989) Nature 339, 476-478 [CrossRef][Medline] [Order article via Infotrieve]
  29. Andersen, J. P., and Vilsen, B. (1992) J. Biol. Chem. 267, 19383-19387 [Abstract/Free Full Text]
  30. Andersen, J. P., and Vilsen, B. (1994) J. Biol. Chem. 269, 15931-15936 [Abstract/Free Full Text]
  31. Skerjanc, I. S., Toyofuku, T., Richardson, C., and MacLennan, D. H. (1993) J. Biol. Chem. 268, 15944-15950 [Abstract/Free Full Text]
  32. Shull, G. E., and Greeb, J. (1988) J. Biol. Chem. 263, 8646-8657 [Abstract/Free Full Text]
  33. Vilsen, B., and Andersen, J. P. (1992) J. Biol. Chem. 267, 25739-25743 [Abstract/Free Full Text]
  34. Rice, W. J., and MacLennan, D. H. (1996) J. Biol. Chem. 271, 31412-31419 [Abstract/Free Full Text]
  35. Rice, W. J., Green, N. M., and MacLennan, D. H. (1997) J. Biol. Chem. 272, in press
  36. Andersen, J. P. (1995) J. Biol. Chem. 270, 908-914 [Abstract/Free Full Text]
  37. Chen, L., Sumbilla, C., Lewis, D., Zhong, L., Strock, C., Kirtley, M. E., and Inesi, G. (1996) J. Biol. Chem. 271, 10745-10752 [Abstract/Free Full Text]
  38. Falson, P., Menguy, T., Corre, F., Bouneau, L., Gomez de Gracia, A., Soulié, S., Centeno, F., Møller, J. V., Champeil, P., and le Maire, M. (1997) J. Biol. Chem. 272, 17258-17262 [Abstract/Free Full Text]
  39. Maruyama, K., Clarke, D. M., Fujii, J., Inesi, G., Loo, T. W., and MacLennan, D. H. (1989) J. Biol. Chem. 264, 13038-13042 [Abstract/Free Full Text]
  40. Clarke, D. M., Loo, T. W., and MacLennan, D. H. (1990) J. Biol. Chem. 265, 22223-22227 [Abstract/Free Full Text]
  41. McIntosh, D. B., Woolley, D. G., Vilsen, B., and Andersen, J. P. (1996) J. Biol. Chem. 271, 25778-25789 [Abstract/Free Full Text]
  42. McIntosh, D. B. (1992) J. Biol. Chem. 267, 22328-22335 [Abstract/Free Full Text]
  43. Blasie, J. K., Herbette, L. G., Pascolini, D., Skita, V., Pierce, D. H., and Scarpa, A. (1985) Biophys. J. 48, 9-18 [Medline] [Order article via Infotrieve]
  44. Cheong, G. W., Young, H. S., Ogawa, H., Toyoshima, C., and Stokes, D. L. (1996) Biophys. J. 70, 1689-1699 [Medline] [Order article via Infotrieve]
  45. Girardet, J. L., and Dupont, Y. (1992) FEBS Lett. 296, 103-106 [CrossRef][Medline] [Order article via Infotrieve]
  46. Bigelow, D. J., and Inesi, G. (1992) Biochim. Biophys. Acta 1113, 323-338 [Medline] [Order article via Infotrieve]
  47. Barth, A., von Germar, F., Kreutz, W., and Mantele, W. (1996) J. Biol. Chem. 271, 30637-30646 [Abstract/Free Full Text]
  48. Troullier, A., Gerwert, K., and Dupont, Y. (1996) Biophys. J. 71, 2970-2983 [Medline] [Order article via Infotrieve]
  49. Canet, D., Forge, V., Guillain, F., and Mintz, E. (1996) J. Biol. Chem. 271, 20566-20572 [Abstract/Free Full Text]

Volume 272, Number 46, Issue of November 14, 1997 pp. 28815-28818
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Phil Trans R Soc AHome page
J. T. Koivumaki, J. Takalo, T. Korhonen, P. Tavi, and M. Weckstrom
Modelling sarcoplasmic reticulum calcium ATPase and its regulation in cardiac myocytes
Phil Trans R Soc A, June 13, 2009; 367(1896): 2181 - 2202.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. H. Fu and A. R. Tupling
Protective effects of Hsp70 on the structure and function of SERCA2a expressed in HEK-293 cells during heat stress
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1175 - H1183.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. Sacchetto, S. Testoni, A. Gentile, E. Damiani, M. Rossi, R. Liguori, C. Drogemuller, and F. Mascarello
A Defective SERCA1 Protein Is Responsible for Congenital Pseudomyotonia in Chianina Cattle
Am. J. Pathol., February 1, 2009; 174(2): 565 - 573.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
E. Vafiadaki, D. A. Arvanitis, S. N. Pagakis, V. Papalouka, D. Sanoudou, A. Kontrogianni-Konstantopoulos, and E. G. Kranias
The Anti-apoptotic Protein HAX-1 Interacts with SERCA2 and Regulates Its Protein Levels to Promote Cell Survival
Mol. Biol. Cell, January 1, 2009; 20(1): 306 - 318.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Yamasaki, G. Wang, T. Daiho, S. Danko, and H. Suzuki
Roles of Tyr122-hydrophobic Cluster and K+ Binding in Ca2+-releasing Process of ADP-insensitive Phosphoenzyme of Sarcoplasmic Reticulum Ca2+-ATPase
J. Biol. Chem., October 24, 2008; 283(43): 29144 - 29155.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. A. Mahmmoud
Capsaicin Stimulates Uncoupled ATP Hydrolysis by the Sarcoplasmic Reticulum Calcium Pump
J. Biol. Chem., August 1, 2008; 283(31): 21418 - 21426.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Marchand, A.-M. L. Winther, P. J. Holm, C. Olesen, C. Montigny, B. Arnou, P. Champeil, J. D. Clausen, B. Vilsen, J. P. Andersen, et al.
Crystal Structure of D351A and P312A Mutant Forms of the Mammalian Sarcoplasmic Reticulum Ca2+-ATPase Reveals Key Events in Phosphorylation and Ca2+ Release
J. Biol. Chem., May 23, 2008; 283(21): 14867 - 14882.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Ruf and W. Arnold
Effects of polyunsaturated fatty acids on hibernation and torpor: a review and hypothesis
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R1044 - R1052.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. R. Tupling, C. Vigna, R. J. Ford, S. C. Tsuchiya, D. A. Graham, S. G. Denniss, and J. W. E. Rush
Effects of buthionine sulfoximine treatment on diaphragm contractility and SR Ca2+ pump function in rats
J Appl Physiol, December 1, 2007; 103(6): 1921 - 1928.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Daiho, K. Yamasaki, S. Danko, and H. Suzuki
Critical Role of Glu40-Ser48 Loop Linking Actuator Domain and First Transmembrane Helix of Ca2+-ATPase in Ca2+ Deocclusion and Release from ADP-insensitive Phosphoenzyme
J. Biol. Chem., November 23, 2007; 282(47): 34429 - 34447.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Tadini-Buoninsegni, G. Bartolommei, M. R. Moncelli, R. Guidelli, and G. Inesi
Pre-steady State Electrogenic Events of Ca2+/H+ Exchange and Transport by the Ca2+-ATPase
J. Biol. Chem., December 8, 2006; 281(49): 37720 - 37727.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Acevedo-Suarez, D. M. Kilkenny, M. B. Reich, and J. W. Thomas
Impaired Intracellular Calcium Mobilization and NFATc1 Availability in Tolerant Anti-Insulin B Cells
J. Immunol., August 15, 2006; 177(4): 2234 - 2241.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Miyauchi, T. Daiho, K. Yamasaki, H. Takahashi, A. Ishida-Yamamoto, S. Danko, H. Suzuki, and H. Iizuka
Comprehensive Analysis of Expression and Function of 51 Sarco(endo)plasmic Reticulum Ca2+-ATPase Mutants Associated with Darier Disease
J. Biol. Chem., August 11, 2006; 281(32): 22882 - 22895.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Masaki, N. Yasokawa, M. Tohnishi, T. Nishimatsu, K. Tsubata, K. Inoue, K. Motoba, and T. Hirooka
Flubendiamide, a Novel Ca2+ Channel Modulator, Reveals Evidence for Functional Cooperation between Ca2+ Pumps and Ca2+ Release
Mol. Pharmacol., May 1, 2006; 69(5): 1733 - 1739.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Bartolommei, F. Tadini-Buoninsegni, S. Hua, M. R. Moncelli, G. Inesi, and R. Guidelli
Clotrimazole Inhibits the Ca2+-ATPase (SERCA) by Interfering with Ca2+ Binding and Favoring the E2 Conformation
J. Biol. Chem., April 7, 2006; 281(14): 9547 - 9551.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Obara, N. Miyashita, C. Xu, I. Toyoshima, Y. Sugita, G. Inesi, and C. Toyoshima
Inaugural Article: Structural role of countertransport revealed in Ca2+ pump crystal structure in the absence of Ca2+
PNAS, October 11, 2005; 102(41): 14489 - 14496.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Jidenko, R. C. Nielsen, T. L.-M. Sorensen, J. V. Moller, M. le Maire, P. Nissen, and C. Jaxel
Crystallization of a mammalian membrane protein overexpressed in Saccharomyces cerevisiae
PNAS, August 16, 2005; 102(33): 11687 - 11691.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
T. Kimura, M. Nakamori, J. D. Lueck, P. Pouliquin, F. Aoike, H. Fujimura, R. T. Dirksen, M. P. Takahashi, A. F. Dulhunty, and S. Sakoda
Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1
Hum. Mol. Genet., August 1, 2005; 14(15): 2189 - 2200.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Wang, K. Yamasaki, T. Daiho, and H. Suzuki
Critical Hydrophobic Interactions between Phosphorylation and Actuator Domains of Ca2+-ATPase for Hydrolysis of Phosphorylated Intermediate
J. Biol. Chem., July 15, 2005; 280(28): 26508 - 26516.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Clausen and J. P. Andersen
Functional Consequences of Alterations to Thr247, Pro248, Glu340, Asp813, Arg819, and Arg822 at the Interfaces between Domain P, M3, and L6-7 of Sarcoplasmic Reticulum Ca2+-ATPase: ROLES IN Ca2+ INTERACTION AND PHOSPHOENZYME PROCESSING
J. Biol. Chem., December 24, 2004; 279(52): 54426 - 54437.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Christensen, A. Shtifman, P. D. Allen, J. R. Lopez, and H. W. Querfurth
Calcium Dyshomeostasis in {beta}-Amyloid and Tau-bearing Skeletal Myotubes
J. Biol. Chem., December 17, 2004; 279(51): 53524 - 53532.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. R. Tupling, A. O. Gramolini, T. A. Duhamel, H. Kondo, M. Asahi, S. C. Tsuchiya, M. J. Borrelli, J. R. Lepock, K. Otsu, M. Hori, et al.
HSP70 Binds to the Fast-twitch Skeletal Muscle Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA1a) and Prevents Thermal Inactivation
J. Biol. Chem., December 10, 2004; 279(50): 52382 - 52389.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
H. Hirata, L. Saint-Amant, J. Waterbury, W. Cui, W. Zhou, Q. Li, D. Goldman, M. Granato, and J. Y. Kuwada
accordion, a zebrafish behavioral mutant, has a muscle relaxation defect due to a mutation in the ATPase Ca2+ pump SERCA1
Development, November 1, 2004; 131(21): 5457 - 5468.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
X. Cai and J. Lytton
The Cation/Ca2+ Exchanger Superfamily: Phylogenetic Analysis and Structural Implications
Mol. Biol. Evol., September 1, 2004; 21(9): 1692 - 1703.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Li, M. Ge, L. Ciani, G. Kuriakose, E. J. Westover, M. Dura, D. F. Covey, J. H. Freed, F. R. Maxfield, J. Lytton, et al.
Enrichment of Endoplasmic Reticulum with Cholesterol Inhibits Sarcoplasmic-Endoplasmic Reticulum Calcium ATPase-2b Activity in Parallel with Increased Order of Membrane Lipids: IMPLICATIONS FOR DEPLETION OF ENDOPLASMIC RETICULUM CALCIUM STORES AND APOPTOSIS IN CHOLESTEROL-LOADED MACROPHAGES
J. Biol. Chem., August 27, 2004; 279(35): 37030 - 37039.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Sato, K. Yamasaki, T. Daiho, Y. Miyauchi, H. Takahashi, A. Ishida-Yamamoto, S. Nakamura, H. Iizuka, and H. Suzuki
Distinct Types of Abnormality in Kinetic Properties of Three Darier Disease-causing Sarco(endo)plasmic Reticulum Ca2+-ATPase Mutants That Exhibit Normal Expression and High Ca2+ Transport Activity
J. Biol. Chem., August 20, 2004; 279(34): 35595 - 35603.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Lenoir, M. Picard, J. V. Moller, M. le Maire, P. Champeil, and P. Falson
Involvement of the L6-7 Loop in SERCA1a Ca2+-ATPase Activation by Ca2+ (or Sr2+) and ATP
J. Biol. Chem., July 30, 2004; 279(31): 32125 - 32133.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-D. Horisberger, S. Kharoubi-Hess, S. Guennoun, and O. Michielin
The Fourth Transmembrane Segment of the Na,K-ATPase {alpha} Subunit: A SYSTEMATIC MUTAGENESIS STUDY
J. Biol. Chem., July 9, 2004; 279(28): 29542 - 29550.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Einholm, B. Vilsen, and J. P. Andersen
Importance of Transmembrane Segment M1 of the Sarcoplasmic Reticulum Ca2+-ATPase in Ca2+ Occlusion and Phosphoenzyme Processing
J. Biol. Chem., April 16, 2004; 279(16): 15888 - 15896.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Danko, K. Yamasaki, T. Daiho, and H. Suzuki
Distinct Natures of Beryllium Fluoride-bound, Aluminum Fluoride-bound, and Magnesium Fluoride-bound Stable Analogues of an ADP-insensitive Phosphoenzyme Intermediate of Sarcoplasmic Reticulum Ca2+-ATPase: CHANGES IN CATALYTIC AND TRANSPORT SITES DURING PHOSPHOENZYME HYDROLYSIS
J. Biol. Chem., April 9, 2004; 279(15): 14991 - 14998.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. SPAT and L. HUNYADY
Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways
Physiol Rev, April 1, 2004; 84(2): 489 - 539.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. D. Clausen, B. Vilsen, D. B. McIntosh, A. P. Einholm, and J. P. Andersen
Glutamate-183 in the conserved TGES motif of domain A of sarcoplasmic reticulum Ca2+-ATPase assists in catalysis of E2/E2P partial reactions
PNAS, March 2, 2004; 101(9): 2776 - 2781.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. R. Bidasee, Y. Zhang, C. H. Shao, M. Wang, K. P. Patel, U. D. Dincer, and H. R. Besch
Diabetes Increases Formation of Advanced Glycation End Products on Sarco(endo)plasmic Reticulum Ca2+-ATPase
Diabetes, February 1, 2004; 53(2): 463 - 473.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Yamasaki, T. Daiho, S. Danko, and H. Suzuki
Multiple and Distinct Effects of Mutations of Tyr122, Glu123, Arg324, and Arg334 Involved in Interactions between the Top Part of Second and Fourth Transmembrane Helices in Sarcoplasmic Reticulum Ca2+-ATPase: CHANGES IN CYTOPLASMIC DOMAIN ORGANIZATION DURING ISOMETRIC TRANSITION OF PHOSPHOENZYME INTERMEDIATE AND SUBSEQUENT Ca2+ RELEASE
J. Biol. Chem., January 16, 2004; 279(3): 2202 - 2210.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. B. Koenderink, S. Geibel, E. Grabsch, J. J. H. H. M. De Pont, E. Bamberg, and T. Friedrich
Electrophysiological Analysis of the Mutated Na,K-ATPase Cation Binding Pocket
J. Biol. Chem., December 19, 2003; 278(51): 51213 - 51222.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Dode, J. P. Andersen, N. Leslie, J. Dhitavat, B. Vilsen, and A. Hovnanian
Dissection of the Functional Differences between Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) 1 and 2 Isoforms and Characterization of Darier Disease (SERCA2) Mutants by Steady-state and Transient Kinetic Analyses
J. Biol. Chem., November 28, 2003; 278(48): 47877 - 47889.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Chen, D. L. Stokes, W. J. Rice, and L. R. Jones
Spatial and Dynamic Interactions between Phospholamban and the Canine Cardiac Ca2+ Pump Revealed with Use of Heterobifunctional Cross-linking Agents
J. Biol. Chem., November 28, 2003; 278(48): 48348 - 48356.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Daiho, K. Yamasaki, G. Wang, S. Danko, H. Iizuka, and H. Suzuki
Deletions of Any Single Residues in Glu40-Ser48 Loop Connecting A Domain and the First Transmembrane Helix of Sarcoplasmic Reticulum Ca2+-ATPase Result in Almost Complete Inhibition of Conformational Transition and Hydrolysis of Phosphoenzyme Intermediate
J. Biol. Chem., October 3, 2003; 278(40): 39197 - 39204.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
G. Wennemuth, D. F. Babcock, and B. Hille
Calcium Clearance Mechanisms of Mouse Sperm
J. Gen. Physiol., June 30, 2003; 122(1): 115 - 128.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Fairclough, L. Dode, J. Vanoevelen, J. P. Andersen, L. Missiaen, L. Raeymaekers, F. Wuytack, and A. Hovnanian
Effect of Hailey-Hailey Disease Mutations on the Function of a New Variant of Human Secretory Pathway Ca2+/Mn2+-ATPase (hSPCA1)
J. Biol. Chem., June 27, 2003; 278(27): 24721 - 24730.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
O. Vazquez-Martinez, R. Canedo-Merino, M. Diaz-Munoz, and J. R. Riesgo-Escovar
Biochemical characterization, distribution and phylogenetic analysis of Drosophila melanogaster ryanodine and IP3 receptors, and thapsigargin-sensitive Ca2+ ATPase
J. Cell Sci., June 15, 2003; 116(12): 2483 - 2494.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Asahi, Y. Sugita, K. Kurzydlowski, S. De Leon, M. Tada, C. Toyoshima, and D. H. MacLennan
Sarcolipin regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban
PNAS, April 29, 2003; 100(9): 5040 - 5045.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Pan, E. Zvaritch, A. R. Tupling, W. J. Rice, S. de Leon, M. Rudnicki, C. McKerlie, B. L. Banwell, and D. H. MacLennan
Targeted Disruption of the ATP2A1 Gene Encoding the Sarco(endo)plasmic Reticulum Ca2+ ATPase Isoform 1 (SERCA1) Impairs Diaphragm Function and Is Lethal in Neonatal Mice
J. Biol. Chem., April 4, 2003; 278(15): 13367 - 13375.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Toustrup-Jensen and B. Vilsen
Importance of Conserved Thr214 in Domain A of the Na+,K+-ATPase for Stabilization of the Phosphoryl Transition State Complex in E2P Dephosphorylation
J. Biol. Chem., March 21, 2003; 278(13): 11402 - 11410.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kato, M. Kamidochi, T. Daiho, K. Yamasaki, W. Gouli, and H. Suzuki
Val200 Residue in Lys189-Lys205 Outermost Loop on the A Domain of Sarcoplasmic Reticulum Ca2+-ATPase Is Critical for Rapid Processing of Phosphoenzyme Intermediate after Loss of ADP Sensitivity
J. Biol. Chem., March 7, 2003; 278(11): 9624 - 9629.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Toyoshima, M. Asahi, Y. Sugita, R. Khanna, T. Tsuda, and D. H. MacLennan
Inaugural Article: Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase
PNAS, January 21, 2003; 100(2): 467 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Grewer, N. Watzke, T. Rauen, and A. Bicho
Is the Glutamate Residue Glu-373 the Proton Acceptor of the Excitatory Amino Acid Carrier 1?
J. Biol. Chem., January 17, 2003; 278(4): 2585 - 2592.
[Abstract] [Full Text] [PDF]


Home page
Reviews in Mineralogy and GeochemistryHome page
A. H. Knoll and A. H. Knoll
Biomineralization and Evolutionary History
Reviews in Mineralogy and Geochemistry, January 1, 2003; 54(1): 329 - 356.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. P. Aiello, L. Fu, A. Miseta, and D. M. Bedwell
Intracellular Glucose 1-Phosphate and Glucose 6-Phosphate Levels Modulate Ca2+ Homeostasis in Saccharomyces cerevisiae
J. Biol. Chem., November 22, 2002; 277(48): 45751 - 45758.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Dode, B. Vilsen, K. Van Baelen, F. Wuytack, J. D. Clausen, and J. P. Andersen
Dissection of the Functional Differences between Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) 1 and 3 Isoforms by Steady-state and Transient Kinetic Analyses
J. Biol. Chem., November 15, 2002; 277(47): 45579 - 45591.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. V. Moller, G. Lenoir, C. Marchand, C. Montigny, M. le Maire, C. Toyoshima, B. S. Juul, and P. Champeil
Calcium Transport by Sarcoplasmic Reticulum Ca2+-ATPase. ROLE OF THE A DOMAIN AND ITS C-TERMINAL LINK WITH THE TRANSMEMBRANE REGION
J. Biol. Chem., October 4, 2002; 277(41): 38647 - 38659.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
Z. Wu, F. Liang, B. Hong, J. C. Young, M. R. Sussman, J. F. Harper, and H. Sze
An Endoplasmic Reticulum-Bound Ca2+/Mn2+ Pump, ECA1, Supports Plant Growth and Confers Tolerance to Mn2+ Stress
Plant Physiology, September 1, 2002; 130(1): 128 - 137.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. R. Jones, R. L. Cornea, and Z. Chen
Close Proximity between Residue 30 of Phospholamban and Cysteine 318 of the Cardiac Ca2+ Pump Revealed by Intermolecular Thiol Cross-linking
J. Biol. Chem., July 26, 2002; 277(31): 28319 - 28329.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Asahi, K. Kurzydlowski, M. Tada, and D. H. MacLennan
Sarcolipin Inhibits Polymerization of Phospholamban to Induce Superinhibition of Sarco(endo)plasmic Reticulum Ca2+-ATPases (SERCAs)
J. Biol. Chem., July 19, 2002; 277(30): 26725 - 26728.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Lax, F. Soler, and F. Fernandez-Belda
Inhibition of sarcoplasmic reticulum Ca2+-ATPase by miconazole
Am J Physiol Cell Physiol, July 1, 2002; 283(1): C85 - C92.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Nakamura, G. Tajima, C. Sato, T. Furukohri, and K. Konishi
Substrate Regulation of Calcium Binding in Ca2+-ATPase Molecules of the Sarcoplasmic Reticulum. I. EFFECT OF ATP
J. Biol. Chem., June 28, 2002; 277(27): 24180 - 24190.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Nakamura, G. Tajima, and C. Sato
Substrate Regulation of Calcium Binding in Ca2+-ATPase Molecules of the Sarcoplasmic Reticulum. II. EFFECT OF CTP, GTP, ITP, AND UTP
J. Biol. Chem., June 28, 2002; 277(27): 24191 - 24196.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Yamasaki, T. Daiho, and H. Suzuki
Remarkable Stability of Solubilized and Delipidated Sarcoplasmic Reticulum Ca2+-ATPase with Tightly Bound Fluoride and Magnesium against Detergent-induced Denaturation
J. Biol. Chem., April 12, 2002; 277(16): 13615 - 13619.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Menguy, F. Corre, B. Juul, L. Bouneau, D. Lafitte, P. J. Derrick, P. S. Sharma, P. Falson, B. A. Levine, J. V. Moller, et al.
Involvement of the Cytoplasmic Loop L6-7 in the Entry Mechanism for Transport of Ca2+ through the Sarcoplasmic Reticulum Ca2+-ATPase
J. Biol. Chem., April 5, 2002; 277(15): 13016 - 13028.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. Tupling and H. Green
Silver ions induce Ca2+ release from the SR in vitro by acting on the Ca2+ release channel and the Ca2+ pump
J Appl Physiol, April 1, 2002; 92(4): 1603 - 1610.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. GUERINI, F. GUIDI, and E. CARAFOLI
Differential membrane targeting of the SERCA and PMCA calcium pumps: experiments with recombinant chimeras
FASEB J, April 1, 2002; 16(6): 519 - 528.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Kimura and M. Inui
Reconstitution of the Cytoplasmic Interaction between Phospholamban and Ca2+-ATPase of Cardiac Sarcoplasmic Reticulum
Mol. Pharmacol., March 1, 2002; 61(3): 667 - 673.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. Culligan, N. Banville, P. Dowling, and K. Ohlendieck
Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle
J Appl Physiol, February 1, 2002; 92(2): 435 - 445.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. R. Zwaal, K. Van Baelen, J. T. M. Groenen, A. van Geel, V. Rottiers, T. Kaletta, L. Dode, L. Raeymaekers, F. Wuytack, and T. Bogaert
The Sarco-Endoplasmic Reticulum Ca2+ ATPase Is Required for Development and Muscle Function in Caenorhabditis elegans
J. Biol. Chem., November 16, 2001; 276(47): 43557 - 43563.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Shigaki, N.-h. Cheng, J. K. Pittman, and K. Hirschi
Structural Determinants of Ca2+ Transport in the Arabidopsis H+/Ca2+ Antiporter CAX1
J. Biol. Chem., November 9, 2001; 276(46): 43152 - 43159.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Asahi, N. M. Green, K. Kurzydlowski, M. Tada, and D. H. MacLennan
Phospholamban domain IB forms an interaction site with the loop between transmembrane helices M6 and M7 of sarco(endo)plasmic reticulum Ca2+ ATPases
PNAS, August 28, 2001; 98(18): 10061 - 10066.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. Arima, N. Matsumoto, K. Kishimoto, and N. Akaike
Spontaneous miniature outward currents in mechanically dissociated rat Meynert neurons
J. Physiol., July 1, 2001; 534(1): 99 - 107.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
M. Chami, D. Gozuacik, D. Lagorce, M. Brini, P. Falson, G. Peaucellier, P. Pinton, H. Lecoeur, M.-L. Gougeon, M. le Maire, et al.
SERCA1 Truncated Proteins Unable to Pump Calcium Reduce the Endoplasmic Reticulum Calcium Concentration and Induce Apoptosis
J. Cell Biol., June 11, 2001; 153(6): 1301 - 1314.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Harmon, G. R. Froemming, E. Leisner, D. Pette, and K. Ohlendieck
Plasticity in Skeletal, Cardiac, and Smooth Muscle: Selected Contribution: Low-frequency stimulation of fast muscle affects the abundance of Ca2+-ATPase but not its oligomeric status
J Appl Physiol, January 1, 2001; 90(1): 371 - 379.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Patchornik, R. Goldshleger, and S. J. D. Karlish
The complex ATP-Fe2+ serves as a specific affinity cleavage reagent in ATP-Mg2+ sites of Na,K-ATPase: Altered ligation of Fe2+ (Mg2+) ions accompanies the E1Pright-arrowE2P conformational change
PNAS, October 12, 2000; (2000) 220332897.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
M. W. Berchtold, H. Brinkmeier, and M. Muntener
Calcium Ion in Skeletal Muscle: Its Crucial Role for Muscle Function, Plasticity, and Disease
Physiol Rev, July 1, 2000; 80(3): 1215 - 1265.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
H. L. Roderick, J. D. Lechleiter, and P. Camacho
Cytosolic Phosphorylation of Calnexin Controls Intracellular Ca2+ Oscillations via an Interaction with SERCA2b
J. Cell Biol., June 12, 2000; 149(6): 1235 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Hirata, N. Nakahata, and Y. Ohizumi
Identification of a 97-kDa Mastoparan-Binding Protein Involving in Ca2+ Release from Skeletal Muscle Sarcoplasmic Reticulum
Mol. Pharmacol., June 1, 2000; 57(6): 1235 - 1242.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Asahi, E. McKenna, K. Kurzydlowski, M. Tada, and D. H. MacLennan
Physical Interactions between Phospholamban and Sarco(endo)plasmic Reticulum Ca2+-ATPases Are Dissociated by Elevated Ca2+, but Not by Phospholamban Phosphorylation, Vanadate, or Thapsigargin, and Are Enhanced by ATP
J. Biol. Chem., May 12, 2000; 275(20): 15034 - 15038.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Baranano, H. Wolosker, B.-I. Bae, R. K. Barrow, S. H. Snyder, and C. D. Ferris
A Mammalian Iron ATPase Induced by Iron
J. Biol. Chem., May 12, 2000; 275(20): 15166 - 15173.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. Sudbrak, J. Brown, C. Dobson-Stone, S. Carter, J. Ramser, J. White, E. Healy, M. Dissanayake, M. Larregue, M. Perrussel, et al.
Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca2+ pump
Hum. Mol. Genet., April 12, 2000; 9(7): 1131 - 1140.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. L.-M. Sorensen, Y. Dupont, B. Vilsen, and J. P. Andersen
Fast Kinetic Analysis of Conformational Changes in Mutants of the Ca2+-ATPase of Sarcoplasmic Reticulum
J. Biol. Chem., February 25, 2000; 275(8): 5400 - 5408.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Xu and N. Narayanan
Reversible Inhibition of the Calcium-pumping ATPase in Native Cardiac Sarcoplasmic Reticulum by a Calmodulin-binding Peptide. EVIDENCE FOR CALMODULIN-DEPENDENT REGULATION OF THE Vmax OF CALCIUM TRANSPORT
J. Biol. Chem., February 11, 2000; 275(6): 4407 - 4416.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Webb, Y. M. Khan, J. M. East, and A. G. Lee
The Importance of Carboxyl Groups on the Lumenal Side of the Membrane for the Function of the Ca2+-ATPase of Sarcoplasmic Reticulum
J. Biol. Chem., January 14, 2000; 275(2): 977 - 982.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Asahi, Y. Kimura, K. Kurzydlowski, M. Tada, and D. H. MacLennan
Transmembrane Helix M6 in Sarco(endo)plasmic Reticulum Ca2+-ATPase Forms a Functional Interaction Site with Phospholamban. EVIDENCE FOR PHYSICAL INTERACTIONS AT OTHER SITES
J. Biol. Chem., November 12, 1999; 274(46): 32855 - 32862.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. B. McIntosh, D. G. Woolley, D. H. MacLennan, B. Vilsen, and J. P. Andersen
Interaction of Nucleotides with Asp351 and the Conserved Phosphorylation Loop of Sarcoplasmic Reticulum Ca2+-ATPase
J. Biol. Chem., September 3, 1999; 274(36): 25227 - 25236.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Sakuntabhai, S. Burge, S. Monk, and A. Hovnanian
Spectrum of novel ATP2A2 mutations in patients with Darier's disease
Hum. Mol. Genet., September 1, 1999; 8(9): 1611 - 1619.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
V. L. Ruiz-Perez, S. A. Carter, E. Healy, C. Todd, J. L. Rees, P. M. Steijlen, A. J. Carmichael, H. M. Lewis, D. Hohl, P. Itin, et al.
ATP2A2 mutations in Darier's disease: variant cutaneous phenotypes are associated with missense mutations, but neuropsychiatric features are independent of mutation class
Hum. Mol. Genet., September 1, 1999; 8(9): 1621 - 1630.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G J M Stienen, Z Papp, and R Zaremba
Influence of inorganic phosphate and pH on sarcoplasmic reticular ATPase in skinned muscle fibres of Xenopus laevis
J. Physiol., August 1, 1999; 518(3): 735 - 744.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Blostein, L. Dunbar, M. Mense, R. Scanzano, A. Wilczynska, and M. J. Caplan
Cation Selectivity of Gastric H,K-ATPase and Na,K-ATPase Chimeras
J. Biol. Chem., June 25, 1999; 274(26): 18374 - 18381.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. L. Longland, M. Mezna, and F. Michelangeli
The Mechanism of Inhibition of the Ca2+-ATPase by Mastoparan. MASTOPARAN ABOLISHES COOPERATIVE Ca2+ BINDING
J. Biol. Chem., May 21, 1999; 274(21): 14799 - 14805.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Maechler, E. D. Kennedy, E. Sebo, A. Valeva, T. Pozzan, and C. B. Wollheim
Secretagogues Modulate the Calcium Concentration in the Endoplasmic Reticulum of Insulin-secreting Cells. STUDIES IN AEQUORIN-EXPRESSING INTACT AND PERMEABILIZED INS-1 CELLS
J. Biol. Chem., April 30, 1999; 274(18): 12583 - 12592.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. A. Reinhardt and R. L. Horst
Ca2+-ATPases and their expression in the mammary gland of pregnant and lactating rats
Am J Physiol Cell Physiol, April 1, 1999; 276(4): C796 - C802.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Kraev, N. Kraev, and E. Carafoli
Identification and Functional Expression of the Plasma Membrane Calcium ATPase Gene Family from Caenorhabditis elegans
J. Biol. Chem., February 12, 1999; 274(7): 4254 - 4258.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Or, R. Goldshleger, and S. J. D. Karlish
Characterization of Disulfide Cross-links between Fragments of Proteolyzed Na,K-ATPase. IMPLICATIONS FOR SPATIAL ORGANIZATION OF TRANS-MEMBRANE HELICES
J. Biol. Chem., January 29, 1999; 274(5): 2802 - 2809.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. G. Du and D. H. MacLennan
Functional Consequences of Mutations of Conserved, Polar Amino Acids in Transmembrane Sequences of the Ca2+ Release Channel (Ryanodine Receptor) of Rabbit Skeletal Muscle Sarcoplasmic Reticulum
J. Biol. Chem., November 27, 1998; 273(48): 31867 - 31872.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. L. Smith, M. A. Szegedy, L. M. Kucharski, C. Walker, R. M. Wiet, A. Redpath, M. T. Kaczmarek, and M. E. Maguire
The CorA Mg2+ Transport Protein of Salmonella typhimurium. MUTAGENESIS OF CONSERVED RESIDUES IN THE THIRD MEMBRANE DOMAIN IDENTIFIES A Mg2+ PORE
J. Biol. Chem., October 30, 1998; 273(44): 28663 - 28669.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. Meldolesi and T. Pozzan
The Heterogeneity of ER Ca2+ Stores Has a Key Role in Nonmuscle Cell Signaling and Function
J. Cell Biol., September 21, 1998; 142(6): 1395 - 1398.
[Full Text] [PDF]


Home page
JCBHome page
L. M. John, J. D. Lechleiter, and P. Camacho
Differential Modulation of SERCA2 Isoforms by Calreticulin
J. Cell Biol., August 24, 1998; 142(4): 963 - 973.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Menguy, F. Corre, L. Bouneau, S. Deschamps, J. V. Moller, P. Champeil, M. le Maire, and P. Falson
The Cytoplasmic Loop Located between Transmembrane Segments 6 and 7 Controls Activation by Ca2+ of Sarcoplasmic Reticulum Ca2+-ATPase
J. Biol. Chem., August 7, 1998; 273(32): 20134 - 20143.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. J. Rogue, J.-P. Humbert, A. Meyer, S. Freyermuth, M.-M. Krady, and A. N. Malviya
cAMP-dependent protein kinase phosphorylates and activates nuclear Ca2+-ATPase
PNAS, August 4, 1998; 95(16): 9178 - 9183.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. T Rapundalo
Cardiac protein phosphorylation: functional and pathophysiological correlates
Cardiovasc Res, June 1, 1998; 38(3): 559 - 588.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. J. Rice, N. M. Green, and D. H. MacLennan
Site-directed Disulfide Mapping of Helices M4 and M6 in the Ca2+ Binding Domain of SERCA1a, the Ca2+ ATPase of Fast Twitch Skeletal Muscle Sarcoplasmic Reticulum
J. Biol. Chem., December 12, 1997; 272(50): 31412 - 31419.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Ambesi, M. Miranda, K. E. Allen, and C. W. Slayman
Stalk Segment 4 of the Yeast Plasma Membrane H+-ATPase. MUTATIONAL EVIDENCE FOR A ROLE IN THE E1-E2 CONFORMATIONAL CHANGE
J. Biol. Chem., June 30, 2000; 275(27): 20545 - 20550.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. C. Curran, I. Hwang, J. Corbin, S. Martinez, D. Rayle, H. Sze, and J. F. Harper
Autoinhibition of a Calmodulin-dependent Calcium Pump Involves a Structure in the Stalk That Connects the Transmembrane Domain to the ATPase Catalytic Domain
J. Biol. Chem., September 22, 2000; 275(39): 30301 - 30308.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacLennan, D. H.
Right arrow Articles by Green, N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacLennan, D. H.
Right arrow Articles by Green, N. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement